ExCEEd Orphan announces new organizational structure and related appointments
ExCEEd Orphan s.r.o., a Czech based multinational company providing full business solutions in
ExCEEd Orphan announces opening of the first foreign affiliate in Croatia
The ExCEEd Orphan s.r.o., a Czech based multinational company providing full business solutions
ExCEEd Orphan cooperation with Kyowa Kirin extended for Romania
The ExCEEd Orphan announces its consulting cooperation extension with Kyowa Kirin (https://www.kyowakirin.com/) in
ExCEEd Orphan initiates cooperation with Novartis Hungary for Zolgensma®
The ExCEEd Orphan announces initiation of its consulting cooperation with Novar-tis Hungary for
ExCEEd Orphan continues cooperation with AveXis for Zolgensma®
AveXis continues in cooperation with ExCEEd Orphan in North Macedonia for Zolgensma®, the
AveXis receives EC approval for Zolgensma®
AveXis receives EC approval and activates “Day One” access program for Zolgensma®, the
First SMA Patient in Czechia was treated with gene therapy in Faculty Hospital in Motol
Little Max is the first patient with spinal muscular atrophy who received systemic
Gene Therapy reimbursed for SMA patients in Czechia
Czech Health Insurance companies recently approved reimbursement of breakthrough gene therapy treatment for
Eurodis and Covid 19 Pandemic
April 8, 2020 EURORDIS open letter to policy makers: Recommendations to protect people